Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

Kilickap, S.Öztürk, A.Karadurmuş, N.Korkmaz, T.Yumuk, P.Cicin, İrfanTunali, D.Yetişyiğit, Tarkan2022-05-112022-05-1120181556-08641556-1380https://hdl.handle.net/20.500.11776/8979[No Abstract Available]eninfo:eu-repo/semantics/closedAccessNSCLCALK inhibitorcrizotinibCrizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from TurkeyConference Object1310S477S478Q1WOS:000454014501235